Bicycle therapeutics to participate in upcoming investor conferences

Cambridge, england & boston--(business wire)--bicycle therapeutics plc (nasdaq: bcyc), a pharmaceutical company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (bicycle®) technology, today announced that management will participate in the following investor conferences in june: jefferies global healthcare conference on wednesday, june 5, 2024; fireside chat at 8:30 a.m. et goldman sachs 45th annual global healthcare conference on monday, june.
BCYC Ratings Summary
BCYC Quant Ranking